Arnaud Techine

Title: Arnaud Techine: Innovator in Binding Molecules

Introduction

Arnaud Techine is a notable inventor based in Oxon, GB. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that have potential applications in treating malignant diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Arnaud Techine holds a patent for binding molecules that comprise T cell receptor (TCR) variable domains. This invention specifically relates to molecules that can bind to a PRAME peptide-HLA complex, particularly the PYLGQMINL (SEQ ID NO: 1) in complex with HLA-A24. The implications of this invention are profound, as it opens new avenues for the treatment of various malignant diseases.

Career Highlights

Techine is currently associated with Immunocore Limited, a company that focuses on developing innovative therapies for cancer and other serious diseases. His role at Immunocore has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Arnaud has worked alongside talented individuals such as Jakub Jaworski and Kate Atkin. These collaborations have enriched his research and fostered an environment of innovation and creativity.

Conclusion

Arnaud Techine's work in binding molecules exemplifies the spirit of innovation in biotechnology. His contributions not only enhance our understanding of T cell receptors but also pave the way for new therapeutic strategies against cancer.